• Arterra Bioscience’s board meets February 10, 2027, to review 2026 revenue; March 30 to approve annual financial statements.
• Shareholders meet April 29, 2027, to approve the annual accounts, with a second call scheduled for April 30.
• Board meetings to review 2027 revenue are scheduled for May 6 for the first quarter; July 14 for the first half.
• The board meets September 29, 2027, to approve the first-half financial report.
• A further board meeting on October 29, 2027, will review nine-month revenue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arterra Bioscience S.p.A. published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 20175_173349_2026_oneinfo.pdf), on November 05, 2026, and is solely responsible for the information contained therein.